Melissa F Halvorson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1005 S Us Highway 27 Ste 100, Saint Johns, MI 48879 Phone: 989-224-3000 Fax: 989-668-0423 |
News Archive
Haemonetics Corporation, a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. This arrangement provides Haemonetics with exclusive access to Alba's comprehensive catalogue of approved reagents for use in connection with the commercialization of its Arryx laser based blood typing platform.
In an era of increasing death and illness from heart and blood vessel disease - which also can impair kidney function - Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches.
Case Western Reserve University School of Medicine has received a $14.7 million, nine-year contract from the National Institutes of Health to be one of five institutions to lead a trial to determine if lowering systolic blood pressure in hypertensive patients, without diabetes, to below the currently recommended level can reduce the incidence of cardiovascular and kidney disease and slow cognitive decline.
Researchers at the University of Cincinnati and UC Health will host a Phase 2 clinical trial (NCT04511650) to examine the effects of a drug that targets blood vessel inflammation and injury in patients with COVID-19.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
› Verified 7 days ago